The expression analysis of ICOS-L on activated T cells and immature dendritic cells as well as malignant B cells and Grave's-disease-derived thyroid tissues by two novel mAbs against human ICOS-L

Tissue Antigens

Volumn 69, Issue 1, 2007, Pages 62-72

  Wang, F ^a,b   Zhu, W ^a   Liu, T ^a   Sun, Z ^a   Ju, S ^a,a   Yu, G ^a   Xie, W ^a   Deng, Z ^a   Lu, B ^a   Zhang, X ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY   (China)

Author keywords

Activated T cells; B lymphoma; ICOS L; Immature monocyte derived dendritic cell; Monoclonal antibody; Thyroid tissues

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; EPITOPE; INDUCIBLE COSTIMULATOR LIGAND; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL CLONING; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; GRAVES DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKEMIA CELL LINE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; DENDRITIC CELLS; GRAVES DISEASE; HL-60 CELLS; HUMANS; JURKAT CELLS; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; PROTEINS; T-LYMPHOCYTES; THYROID GLAND;

EID: 33845897917     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00706.x     Document Type: Article

References (26)

1. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994: 76: 275-85.
2. Jenkins MK. The ups and downs of T cell costimulation. Immunity 1991: 1: 443-6.
3. Boise LH, Minn AJ, Noel PJ et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 1995: 3: 87-98.
4. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996: 14: 233-258.
5. Saloman B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001: 19: 225-252.
6. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002: 20: 29-53.
7. Ling V, Wu PW, Finnerty H F et al. Cutting edge: identification of ICOS-L, a novel B7-like protein that functionally binds to ICOS receptor. J Immunol 2000: 164: 1653-7.
8. Yoshinaga SK, Zhang M, Pistillo J et al. Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int Immunol 2000: 12: 1439-47.
9. Wang S, Zhu G, Chapoval AI et al. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 2000: 96: 2808-13.
10. Brodie D, Collins AV, Iaboni A et al. LICOS, a primordial costimulatory ligand? Curr Biol 2000: 10: 333-336.
11. Aicher A, Hayden-Ledbetter M, Brady WA et al. Characterization of human inducible costimulator ligand expression and function. J Immunol 2000: 164: 4689-96.
12. Swallow MM, Wallin JJ, Sha WC. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNF-alpha. Immunity 1999: 11: 423-432.
13. Vincent L, Paul WW, Heather FF et al. Cutting edge: identification of ICOS-L, a novel B7-Like protein that functionally binds to ICOS receptor. J Immunol 2000: 164: 1653-7.
14. Hutloff A, Dittrich AM, Beier KC et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999: 397: 263-6.
15. Kopf M, Coyle AJ, Schmitz N et al. Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J Exp Med 2000: 192: 53-61.
16. Akbari O, Freeman GJ, Meyer EH et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002: 8: 1024-32.
17. Wong SC, Oh E, Ng CH et al. Impaired germinal center formation and recall T cell-dependent immune responses in mice lacking the co-stimulatory ligand B7-H2. Blood 2003: 102: 1381-8.
18. Mak TW, Arda S, Steve KY et al. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat Immun 2003: 4: 765-72.
19. Yoshinaga SK, Whoriskey JS, Khare SD et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999: 402: 827-32.
20. Deng ZB, Lu CM, Shen LQ et al. Effects of human ICOS cDNA transfected cells on the production of T-lymphocytes dependent antibodies. Shanghai J Immunol 2003: 23: 314-7.
21. Deng ZB, Zhu W, Lu CM et al. Construction of ICOS-L transfected L929 cells. J China Microbiol Immunol 2003: 23: 404.
22. Zhou ZH, Wang JF, Wang YD et al. An agonist anti-human CD40 mAb that induces dendritic cell formation and maturation and inhibits proliferation of myeloma cell line. Hybridoma 1999: 18: 471-7.
23. Wang Q, Chen Y, Ge Y et al. Characterization and functional study of five novel mAbs against human OX40L highlight reverse signalling: enhancement of IgG production of B cells and promotion of maturation of DCs. Tissue Antigens 2004: 64: 566-74.
24. Zhang GB, Chen YJ, Shi Q et al. Human recombinant B7-H3 expressed in E. coli enhances T lymphocyte proliferation and IL-10 secretion in vitro. Acta Biochim Biophys Sin 2004: 36: 430-6.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods 2001: 25: 402-8.
26. Sun ZW, Qiu YH, Shi YJ et al. Time courses of B7 family molecules expressed on activated T-cells and their biological significance. Cell Immunol 2005: 236: 146-53.